Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating activities:
Net loss	$ (984)	$ (7,037)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,106	562
Reserve for inventory obsolescence	713	123
Change in fair value of preferred stock warrant and contingent shares liability	(1,109)	1,020
Change in fair value of derivative liability	(12,247)
Deferred tax benefit	(21)
Non-cash interest expense	5,473	256
Stock-based compensation	3,808	813
Allowance for credit losses	3,870	596
Loss on debt extinguishment	171	3,613
Non-cash lease expense	996	535
Forgiveness of recourse promissory note and accrued interest		117
Accretion of interest on marketable securities	(508)
Loss on disposal of property and equipment	17
Changes in operating assets and liabilities:
Accounts receivable	5,201	(12,533)
Inventory	(37,199)	(14,969)
Prepaid expenses and other assets	(1,272)	(2,459)
Accounts payable	(8,577)	10,890
Accrued expenses and other liabilities	3,383	952
Deferred revenue	(321)	673
Warranty liability	1,281	958
Deferred rent		(135)
Operating lease liabilities	(1,003)	(447)
Net cash used in operating activities	(37,222)	(16,472)
Investing activities:
Purchase of marketable securities	(53,483)
Cash invested in note receivable		(456)
Acquisition of fSight	(16)
Purchase of intangible assets	(450)
Purchase of property and equipment	(2,114)	(1,147)
Sales and maturities of marketable securities	25,149
Net cash used in investing activities	(30,914)	(1,603)
Financing activities:
Proceeds from Convertible Promissory Note	50,000	25,000
Repayment of Series 2022-1 Notes	(20,833)	(4,165)
Repayment of Senior Bonds		(10,000)
Payment of financing costs	(358)	(3,473)
Proceeds from sale of Series E convertible preferred stock		40,978
Proceeds from Business Combination	2,238
Proceeds from exercise of stock options	215	325
Payment of tax withholdings on stock options	(91)
Payment of deferred issuance costs related to the Merger		(139)
Payment of issuance costs related to the sale of Series E convertible preferred stock		(208)
Proceeds from common stock warrant redemption, net of issuance costs and payments to warrant holders of non-redeemed warrants	3,653
Net cash provided by financing activities	34,824	48,318
Net (decrease) increase in cash and restricted cash	(33,312)	30,243
Cash, cash equivalents, and restricted cash at beginning of period	37,717	7,474
Cash, cash equivalents, and restricted cash at end of period	4,405	37,717
Supplemental disclosure of cash flow information:
Cash paid for interest	1,418	1,238
Cash paid for income taxes, net	95	109
Supplemental schedule of non-cash investing and financing activities:
Financing costs in accounts payable and accrued expenses		2,082
Net assets acquired from ROCG	573
Operating lease right of use assets obtained in exchange for operating lease liabilities	2,247	1,787
Property plant and equipment in accounts payable	693	$ 135
Non-cash consideration paid for the acquisition of fSight	10,974
Contingent shares liability from fSight acquisition	2,167
Fair value of derivative note liability at issuance	23,525
Dividends on Series D and Series E convertible preferred stock	12,581
Reclassification of deferred issuance costs to additional paid in capital	2,221
Conversion of convertible preferred stock into common stock in connection with the Business Combination (Note 3)	87,140
Issuance of preferred stock upon exercise of preferred warrants	2,008
Unrealized loss resulting from change in fair value of marketable securities	(59)
Reclassification of convertible note derivative liability to equity	$ 11,278